Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CLP 137.16 trillion. The enterprise value is 184.58 trillion.

Market Cap	137.16T
Enterprise Value	184.58T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.53%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 19.60 and the forward PE ratio is 9.29.

PE Ratio	19.60
Forward PE	9.29
PS Ratio	2.43
PB Ratio	1.75
P/TBV Ratio	n/a
P/FCF Ratio	16.78
P/OCF Ratio	13.01
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.94, with an EV/FCF ratio of 22.58.

EV / Earnings	26.37
EV / Sales	3.38
EV / EBITDA	7.94
EV / EBIT	11.04
EV / FCF	22.58

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.65%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	6.60%
Revenue Per Employee	751.59M
Profits Per Employee	93.33M
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-239.60B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.71
52-Week Price Change	n/a
50-Day Moving Average	26.06
200-Day Moving Average	26.06
Relative Strength Index (RSI)	0.00
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.06

Income Statement

In the last 12 months, Pfizer had revenue of CLP 56.37 trillion and earned 7.00 trillion in profits. Earnings per share was 1,228.99.

Revenue	56.37T
Gross Profit	42.73T
Operating Income	17.26T
Pretax Income	6.77T
Net Income	7.00T
EBITDA	23.17T
EBIT	17.26T
Earnings Per Share (EPS)	1,228.99

Full Income Statement

Balance Sheet

The company has 12.25 trillion in cash and 60.93 trillion in debt, giving a net cash position of -48,687.52 billion.

Cash & Cash Equivalents	12.25T
Total Debt	60.93T
Net Cash	-48,687.52B
Net Cash Per Share	n/a
Equity (Book Value)	78.16T
Book Value Per Share	13,699.43
Working Capital	5.33T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.54 trillion and capital expenditures -2,368.12 billion, giving a free cash flow of 8.17 trillion.

Operating Cash Flow	10.54T
Capital Expenditures	-2,368.12B
Free Cash Flow	8.17T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 1,593.16, which amounts to a dividend yield of 6,113.43%.

Dividend Per Share	1,593.16
Dividend Yield	6,113.43%
Dividend Growth (YoY)	-1.55%
Years of Dividend Growth	2
Payout Ratio	125.74%
Buyback Yield	-0.23%
Shareholder Yield	6,113.20%
Earnings Yield	5.10%
FCF Yield	5.96%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6